1.14.14.127	1-(2-methylpropyl)-5-[4-([4-[3-(trifluoromethyl)-3H-diaziren-3-yl]benzyl]oxy)phenyl]-1H-imidazole	bifunctional compound, inhibits juvenile hormone III synthesis by intact glands as well as methyl farnesoate epoxidation by gland homogenates. Using the compound, a radiolabeled and photoactivatable diazirine or benzophenone group can be introduced to label the hydrophobic substrate binding site of the enzyme	199390	
1.14.14.127	5-(2-(benzyloxy)phenyl)-1-(3,7-dimethyloct-6-en-1-yl)-1H-imidazole	-	201135	
1.14.14.127	5-(3-[[(2E)-3,7-dimethylocta-2,6-dien-1-yl]oxy]phenyl)-1-(2-methylpropyl)-1H-imidazole	-	196519	
1.14.14.127	5-[3-(benzyloxy)phenyl]-1-(2-methylpropyl)-1H-imidazole	-	196518	
1.14.14.127	carbon monoxide/oxygen atmosphere	half-maximal inhibition at a CO/O ratio of 4.0. Inhibition is reversed by white-light irradiation	201134	
1.14.14.127	cytochrome c	inhibition by oxidized cytochrome c, 20 microM, 52.4% residual activity	84	
1.14.14.127	methyl (2E,6E)-3,7-dimethyl-8-(3,4-methylenedioxyphenoxy)-octadienoate	inhibits juvenile hormone biosynthesis in vitro by spontaneously active glands, presumably by direct inhibition of the epoxidase, and also inhibits the production of total methyl ester	201136	
1.14.14.127	additional information	inhibition 1,5-disubstituted imidazoles	2	
1.14.14.127	NADP+	2 mM, 57.2% residual activity	10	
1.14.14.127	[4-([4-[1-(2-methylpropyl)-1H-imidazol-5-yl]phenoxy]methyl)phenyl](phenyl)methanone	bifunctional compound, inhibits juvenile hormone III synthesis by intact glands as well as methyl farnesoate epoxidation by gland homogenates. Using the compound, a radiolabeled and photoactivatable diazirine or benzophenone group can be introduced to label the hydrophobic substrate binding site of the enzyme	199391